Difference between revisions of "Succinylcholine"
From WikiAnesthesia
Chris Rishel (talk | contribs) m (Added embedded dosage calculation) |
m (add absolute contraindications) |
||
Line 31: | Line 31: | ||
===Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. -->=== | ===Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. -->=== | ||
* hyperkalemia | |||
* increased risk of [[Malignant Hyperthermia|malignant hyperthermia]] | |||
* open globe injury | |||
* allergy | |||
===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->=== | ===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->=== |
Latest revision as of 15:41, 17 July 2022
Succinylcholine
Trade names |
Anectine |
---|---|
Clinical data | |
Drug class |
Depolarizing neuromuscular blocker |
Uses |
Paralysis for intubation |
Contraindications |
History/risk of malignant hyperthermia |
Routes of administration |
Intravenous, intramuscular |
Dosage | |
Pharmacodynamics | |
Mechanism of action |
Depolarizing blockade of neuromuscular junction |
Adverse effects |
Bradycardia, hyperkalemia, malignant hyperthermia, myalgias |
Pharmacokinetics | |
Onset of action |
30-60 seconds (IV) |
Duration of action |
5-10 minutes (IV) |
Metabolism |
Plasma cholinesterase |
Physical and chemical data | |
Article quality | |
Editor rating | |
User likes | 0 |
Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation.
Uses
Contraindications
Absolute contraindications
- hyperkalemia
- increased risk of malignant hyperthermia
- open globe injury
- allergy
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel and huckfinne@gmail.com